Ketamine: The Good, the Bad, and the Deadly
Share
The opioid epidemic continues to dominate today’s headlines, mirroring past substance abuse trends with drugs such as cocaine in the 1980s, heroin in the 1990s, and methamphetamine thereafter. Currently, in the United States, the spotlight is on fentanyl, a synthetic opioid that is up to 100 times more potent than morphine (National Institute on Drug Abuse, 2023a). The grave impact of fentanyl on the opioid crisis is a major concern in the news cycle. However, in the fall of 2023, ketamine, a lesser-known drug, came under scrutiny following the death of actor Mathew Perry.
About Me
Sarah Kelsey, Esq. is the cofounder and Chief Executive Officer (CEO) of the Legislative Analysis and Public Policy Association (LAPPA).
Susan P. Weinstein, Esq. is the co-founder and president of the Legislative Analysis and Public Policy Association (LAPPA) and has almost 30 years of experience with drug and drug-related topics. She has authored numerous publications and presented at various conferences on the intersection of criminal law and substance use.
Current Issue
Counselor Magazine is the official publication of the California Association of Addiction Programs and Professionals (CCAPP). Counselor offers online continuing education, article archives, subscription deals, and article submission guidelines. It has been serving the addiction field for more than thirty years.
For more information on CCAPP’s many programs, certifications, and career paths, please visit ccapp.us.